vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Solo Brands, Inc.（SBDS）财务数据对比。点击上方公司名可切换其他公司
Solo Brands, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$94.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -34.5%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 5.0%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
给定公司标识与企业信息不匹配，本次提供的实为康尼格拉品牌公司信息，该企业是美国上市消费品包装集团，产品在超市、餐饮门店均有售，总部坐落于美国伊利诺伊州芝加哥，1919年创始于美国内布拉斯加州，按2021年营收位列2022年财富世界500强第331位。
PBYI vs SBDS — 直观对比
营收规模更大
SBDS
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出62.2%
-34.5%
两年增速更快
PBYI
近两年复合增速
5.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $94.0M |
| 净利润 | — | $-83.2M |
| 毛利率 | 69.3% | 60.6% |
| 营业利润率 | 22.7% | -81.7% |
| 净利率 | — | -88.4% |
| 营收同比 | 27.7% | -34.5% |
| 净利润同比 | — | -42.9% |
| 每股收益（稀释后） | $0.26 | $-45.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISBDS
| Q4 25 | $75.5M | $94.0M | ||
| Q3 25 | $54.5M | $53.0M | ||
| Q2 25 | $52.4M | $92.3M | ||
| Q1 25 | $46.0M | $77.3M | ||
| Q4 24 | $59.1M | $143.5M | ||
| Q3 24 | $80.5M | $94.1M | ||
| Q2 24 | $47.1M | $131.6M | ||
| Q1 24 | $43.8M | $85.3M |
净利润PBYISBDS
| Q4 25 | — | $-83.2M | ||
| Q3 25 | $8.8M | $-22.9M | ||
| Q2 25 | $5.9M | $-20.8M | ||
| Q1 25 | $3.0M | $-18.6M | ||
| Q4 24 | — | $-58.2M | ||
| Q3 24 | $20.3M | $-111.5M | ||
| Q2 24 | $-4.5M | $-4.0M | ||
| Q1 24 | $-4.8M | $-6.5M |
毛利率PBYISBDS
| Q4 25 | 69.3% | 60.6% | ||
| Q3 25 | 77.7% | 60.0% | ||
| Q2 25 | 76.5% | 61.3% | ||
| Q1 25 | 77.1% | 55.2% | ||
| Q4 24 | 76.4% | 61.1% | ||
| Q3 24 | 63.9% | 41.8% | ||
| Q2 24 | 77.4% | 62.8% | ||
| Q1 24 | 75.5% | 59.2% |
营业利润率PBYISBDS
| Q4 25 | 22.7% | -81.7% | ||
| Q3 25 | 17.6% | -30.5% | ||
| Q2 25 | 12.7% | -10.7% | ||
| Q1 25 | 8.7% | -13.8% | ||
| Q4 24 | 22.6% | -38.5% | ||
| Q3 24 | 27.4% | -122.5% | ||
| Q2 24 | -4.6% | 1.7% | ||
| Q1 24 | -5.3% | -7.4% |
净利率PBYISBDS
| Q4 25 | — | -88.4% | ||
| Q3 25 | 16.2% | -43.2% | ||
| Q2 25 | 11.2% | -22.5% | ||
| Q1 25 | 6.5% | -24.0% | ||
| Q4 24 | — | -40.6% | ||
| Q3 24 | 25.2% | -118.4% | ||
| Q2 24 | -9.6% | -3.1% | ||
| Q1 24 | -11.0% | -7.6% |
每股收益（稀释后）PBYISBDS
| Q4 25 | $0.26 | $-45.73 | ||
| Q3 25 | $0.17 | $-9.22 | ||
| Q2 25 | $0.12 | $-8.93 | ||
| Q1 25 | $0.06 | $-0.21 | ||
| Q4 24 | $0.40 | $-27.74 | ||
| Q3 24 | $0.41 | $-47.72 | ||
| Q2 24 | $-0.09 | $-2.14 | ||
| Q1 24 | $-0.10 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $20.0M |
| 总债务越低越好 | $22.7M | $242.1M |
| 股东权益账面价值 | $130.3M | $46.0M |
| 总资产 | $216.3M | $360.3M |
| 负债/权益比越低杠杆越低 | 0.17× | 5.26× |
8季度趋势，按日历期对齐
现金及短期投资PBYISBDS
| Q4 25 | $97.5M | $20.0M | ||
| Q3 25 | $94.4M | $16.3M | ||
| Q2 25 | $96.0M | $18.1M | ||
| Q1 25 | $93.2M | $206.4M | ||
| Q4 24 | $101.0M | $12.0M | ||
| Q3 24 | $96.7M | $12.5M | ||
| Q2 24 | $96.8M | $20.1M | ||
| Q1 24 | $107.2M | $15.4M |
总债务PBYISBDS
| Q4 25 | $22.7M | $242.1M | ||
| Q3 25 | $34.0M | $235.2M | ||
| Q2 25 | $45.3M | $238.4M | ||
| Q1 25 | $56.7M | $427.9M | ||
| Q4 24 | $68.0M | $150.7M | ||
| Q3 24 | $79.3M | $161.1M | ||
| Q2 24 | $90.7M | $162.2M | ||
| Q1 24 | $102.0M | $170.2M |
股东权益PBYISBDS
| Q4 25 | $130.3M | $46.0M | ||
| Q3 25 | $115.3M | $99.1M | ||
| Q2 25 | $104.7M | $113.2M | ||
| Q1 25 | $97.1M | $121.7M | ||
| Q4 24 | $92.1M | $133.7M | ||
| Q3 24 | $71.1M | $168.0M | ||
| Q2 24 | $48.5M | $236.7M | ||
| Q1 24 | $51.0M | $238.5M |
总资产PBYISBDS
| Q4 25 | $216.3M | $360.3M | ||
| Q3 25 | $202.9M | $431.0M | ||
| Q2 25 | $194.9M | $459.7M | ||
| Q1 25 | $196.2M | $692.4M | ||
| Q4 24 | $213.3M | $495.1M | ||
| Q3 24 | $220.7M | $553.2M | ||
| Q2 24 | $205.0M | $642.0M | ||
| Q1 24 | $214.1M | $648.3M |
负债/权益比PBYISBDS
| Q4 25 | 0.17× | 5.26× | ||
| Q3 25 | 0.30× | 2.37× | ||
| Q2 25 | 0.43× | 2.11× | ||
| Q1 25 | 0.58× | 3.52× | ||
| Q4 24 | 0.74× | 1.13× | ||
| Q3 24 | 1.12× | 0.96× | ||
| Q2 24 | 1.87× | 0.69× | ||
| Q1 24 | 2.00× | 0.71× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $6.4M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYISBDS
| Q4 25 | $14.4M | $6.4M | ||
| Q3 25 | $9.7M | $11.2M | ||
| Q2 25 | $14.1M | $10.9M | ||
| Q1 25 | $3.6M | $-75.2M | ||
| Q4 24 | $15.6M | $13.0M | ||
| Q3 24 | $11.0M | $378.0K | ||
| Q2 24 | $1.0M | $15.7M | ||
| Q1 24 | $11.2M | $-18.5M |
自由现金流PBYISBDS
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | $-78.4M | ||
| Q4 24 | $15.6M | $9.0M | ||
| Q3 24 | $11.0M | $-5.9M | ||
| Q2 24 | $1.0M | $12.8M | ||
| Q1 24 | — | $-20.9M |
自由现金流率PBYISBDS
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | -101.5% | ||
| Q4 24 | 26.4% | 6.3% | ||
| Q3 24 | 13.7% | -6.3% | ||
| Q2 24 | 2.1% | 9.8% | ||
| Q1 24 | — | -24.5% |
资本支出强度PBYISBDS
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | 4.2% | ||
| Q4 24 | 0.0% | 2.8% | ||
| Q3 24 | 0.0% | 6.7% | ||
| Q2 24 | 0.0% | 2.2% | ||
| Q1 24 | 0.0% | 2.8% |
现金转化率PBYISBDS
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
SBDS
| Sales Channel Directly To Consumer | $65.4M | 70% |
| Sales Channel Through Intermediary | $28.6M | 30% |
